Graduate School of Medical Science, Kumamoto Health Science University, Kitaku Izumi-machi 325, Kumamoto 861-5598, Japan; Graduate School of Medical Science, Kumamoto University School of Medicine, Chuo-ku Honjo 1-1-1, Kumamoto 860-8556, Japan.
Graduate School of Medical Science, Kumamoto Health Science University, Kitaku Izumi-machi 325, Kumamoto 861-5598, Japan.
Cytokine. 2017 Nov;99:310-315. doi: 10.1016/j.cyto.2017.08.014. Epub 2017 Aug 30.
Cross-talks between toll-like receptors (TLRs) including various negative regulatory mechanisms are many unknown. We investigated the differential mechanism of IL-23 production in M1 macrophages by single immunoglobulin interleukin-1 receptor-related (SIGIRR) molecule through TLR4 or TLR7/8. IL-12p40 production by M1 macrophages pretreated with human neutrophil elastase (HNE) was synergistically enhanced IL-12p40, but not IL-23 production, after exposure to lipopolysaccharide (LPS). LPS (a TLR4 agonist) induced a slight increase of IL-23 production, while Resiquimod (a TLR7/8 agonist) significantly enhanced IL-23 production. Expression of SIGIRR protein, a negative regulator of TLR4, was higher in M1 macrophages than in monocytes. Interestingly, SIGIRR siRNA induced a slight increment of IL-23 production after exposure of macrophages to LPS, while IL-23 production in response to Resiquimod was significantly upregulated by SIGIRR siRNA. Silencing SIGIRR enhanced IRF4 protein level determined by western blotting or ELISA. IRF4 siRNA dramatically restored IL-23 production after exposure to Resiquimod in macrophages transfected with SIGIRR siRNA. In conclusion, production of IL-23 is differentially regulated in M1 macrophages by SIGIRR through TLR4- or TLR7/8-mediated signaling. SIGIRR is both a negative regulator of TLR4 and a positive regulator of TLR7/8.
TLR 之间的串扰(TLRs)包括各种负调控机制,许多都是未知的。我们通过单免疫球蛋白白细胞介素 1 受体相关(SIGIRR)分子研究了 TLR4 或 TLR7/8 途径中 M1 巨噬细胞中 IL-23 产生的差异机制。用人中性粒细胞弹性蛋白酶(HNE)预处理的 M1 巨噬细胞产生的 IL-12p40,在暴露于脂多糖(LPS)后协同增强 IL-12p40,但不增强 IL-23 产生。LPS(TLR4 激动剂)诱导 IL-23 产生轻微增加,而瑞喹莫德(TLR7/8 激动剂)则显著增强 IL-23 产生。SIGIRR 蛋白,TLR4 的负调节剂,在 M1 巨噬细胞中的表达高于单核细胞。有趣的是,SIGIRR siRNA 在巨噬细胞暴露于 LPS 后诱导 IL-23 产生轻微增加,而 SIGIRR siRNA 则显著上调对瑞喹莫德的 IL-23 产生。沉默 SIGIRR 通过 Western blot 或 ELISA 增强 IRF4 蛋白水平。在转染了 SIGIRR siRNA 的巨噬细胞中,用 Resiquimod 处理后,IRF4 siRNA 显著恢复了 IL-23 的产生。总之,SIGIRR 通过 TLR4 或 TLR7/8 介导的信号通路,对 M1 巨噬细胞中 IL-23 的产生进行差异调控。SIGIRR 既是 TLR4 的负调节剂,也是 TLR7/8 的正调节剂。